CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Recruiting · NCT04318678 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) | CD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Skin and Connective Tissue Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2026-05-19 | NCT04318678 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Jude Children's Research Hospital | 169 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St Jude Children's Research Hospital | Memphis | United States | 10 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |